Clinical trial
RD-40 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance
NCT01503476 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RD-40 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance
- Lead sponsor
- Medtronic - MITG
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- March 31, 2016
- Enrollment
- 170 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastro esophageal reflux disease